These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2180502

  • 1. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
    Safi F, Roscher R, Beger HG.
    Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502
    [Abstract] [Full Text] [Related]

  • 2. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9.
    Safi F, Roscher R, Beger HG.
    Hepatogastroenterology; 1989 Dec; 36(6):419-23. PubMed ID: 2613165
    [Abstract] [Full Text] [Related]

  • 3. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma.
    Lucarotti ME, Habib NA, Kelly SB, Rothnie ND, Nelson O, Lindholm L, Cooper MJ, Wood CB, Williamson RC.
    Eur J Surg Oncol; 1991 Feb; 17(1):51-3. PubMed ID: 1995358
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I.
    Anticancer Res; 1993 Feb; 13(5C):1883-7. PubMed ID: 8267397
    [Abstract] [Full Text] [Related]

  • 6. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
    Ohshio G, Manabe T, Watanabe Y, Endo K, Kudo H, Suzuki T, Tobe T.
    Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
    [Abstract] [Full Text] [Related]

  • 7. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
    Chen YF, Mai CR, Tie ZJ, Feng ZT, Zhang J, Lu XH, Lu GJ, Xue YH, Pan GZ.
    Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
    [Abstract] [Full Text] [Related]

  • 8. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H, Kaya M, Cengiz A.
    Hepatogastroenterology; 2003 May; 50(53):1669-74. PubMed ID: 14571813
    [Abstract] [Full Text] [Related]

  • 9. Serum concentration and immunohistochemical localization of SPan-1 antigen in pancreatic cancer. A comparison with CA19-9 antigen.
    Takeda S, Nakao A, Ichihara T, Suzuki Y, Nonami T, Harada A, Koshikawa T, Takagi H.
    Hepatogastroenterology; 1991 Apr; 38(2):143-8. PubMed ID: 1855772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A.
    Anticancer Res; 1997 Apr; 17(4B):2903-6. PubMed ID: 9329559
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor markers in patients with pancreatic carcinoma.
    Gattani AM, Mandeli J, Bruckner HW.
    Cancer; 1996 Jul 01; 78(1):57-62. PubMed ID: 8646727
    [Abstract] [Full Text] [Related]

  • 17. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun 01; 11(3):229-31. PubMed ID: 2529993
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K, Kanazawa G, Kho I, Chung Y, Umeyama K.
    Am J Gastroenterol; 1985 Aug 01; 80(8):630-6. PubMed ID: 2411125
    [Abstract] [Full Text] [Related]

  • 19. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT, Tao HQ, Zou SC.
    Hepatobiliary Pancreat Dis Int; 2004 Aug 01; 3(3):464-8. PubMed ID: 15313690
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2].
    Ohkura H, Sakawaki T.
    Gan No Rinsho; 1985 May 01; 31(6 Suppl):583-8. PubMed ID: 3861882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.